National Covaxin Safe And Highly Effective In Children Between 2-18 Years Of Age, Shows Study BY Outlook Web Desk
National Covaxin Booster Enhances Antibody Response Against COVID-19 Variants Including Omicron: Study BY Outlook Web Desk
miscellaneous Govt's Decision On Covid Vaccination For Children 'Unscientific': Senior AIIMS Epidemiologist BY Outlook Web Desk
National Father-Daughter Duo Who Risked Life For Vaccine Trial Begs For Jabs For Kin BY Jeevan Prakash Sharma
Making A Difference FDA Has Rejected Covaxin’s Emergency Use In America; Here’s Why BY Outlook Web Bureau
National Covaxin Only For 18-44 Age Group Who Are Eligible For Second Dose: Delhi Govt BY Outlook Web Bureau
National AIIMS Delhi To Start Screening Children For Clinical Trials Of Covaxin From Today BY Outlook Web Bureau
National Covid Explained: How Phase 2 And 3 Trials For Covaxin On Kids Will Be Conducted? BY Outlook Web Bureau
National Experts Recommend Bharat Biotech’s Covaxin For Phase 2/3 Trials On 2-18-Year-Olds BY Outlook Web Bureau
National Covaxin Is 78% Effective Against Mild To Severe Covid-19 Infections: Bharat Biotech BY Outlook Web Bureau
National Health Minister Harsh Vardhan Allays Chhattisgarh's Fears About Covaxin BY Outlook Web Bureau
National How Safe Is It To Have Sex After You Take Covid Vaccine? Experts Advise Caution BY Jeevan Prakash Sharma
National Bhopal: Volunteer Dies 10 Days After Taking Bharat Biotech's Covaxin, Spurs Controversy BY Outlook Web Bureau
National With 25,800 Volunteers, Bharat Biotech Completes Enrollment For Covaxin Phase-3 Trials BY Outlook Web Bureau
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
